1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication

Details for Australian Patent Application No. 2006224533 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Bonfanti, Jean-Francois; Dorange, Ismet; Fortin, Jerome Michel Claude

Agent Shelston IP

Pub. Number AU-B-2006224533

PCT Pub. Number WO2006/097534

Priority 05102127.7 17.03.05 EP

Filing date 17 March 2006

Wipo publication date 21 September 2006

Acceptance publication date 3 May 2012

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4184 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

9 August 2007 PCT application entered the National Phase

  PCT publication WO2006/097534 Priority application(s): WO2006/097534

3 May 2012 Application Accepted

  Published as AU-B-2006224533

30 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006224536-Acylated GLP-1 compounds

2006224529-Cat allergen fusion proteins and uses thereof